Alcohol consumption and probable rapid eye movement sleep behavior disorder

Ma, Chaoran; Pavlova, Milena; Li, Junjuan; Liu, Ying; Sun, Yujie; Huang, Ze; Wu, Shouling; Gao, Xiang

doi:10.1002/acn3.630

Cited by 13 publications

(16 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The analysis was based on a subset of a Chinese cohort, the Kailuan Study, being conducted in the Kailuan community in Tangshan city, China (13) . In the Kailuan Study, 101 510 participants (81 110 men and 20 400 women) from the ages of 18-97 were recruited in 2006-2007 at eleven hospitals (study sites) (13)(14)(15) . These hospitals provide primary care for all participants of the Kailuan Study.…”

Section: Participantsmentioning

confidence: 99%

“…In 2012, information on sleep habits was collected in 12 990 participants (10 725 men and 2265 women) who had completed the survey in the Kailuan Hospital (the largest study site of the Kailuan Study) and were free of neurodegenerative diseases, as detailed previously (13,14) . We excluded participants with CVD, cancer and head injury (n 987) and participants who had incomplete sleep and alcohol intake information (n 98), leaving 11 905 participants (9776 men and 2129 women) in the current analysis.…”

Section: Participantsmentioning

confidence: 99%

See 1 more Smart Citation

Alcohol consumption and sleep quality: a community-based study

Zheng

Yuan

et al. 2020

Public Health Nutr.

Self Cite

View full text Add to dashboard Cite

Objective: To assess the association between total alcohol intake, specific alcoholic beverages, and sleep quality in a community-based cohort. Design: A cross-sectional study. Setting: The Kailuan community, China. Participants: Included were 11,905 participants who were free of a history of cardiovascular diseases, cancer, Parkinson’s disease, dementia, and head injury in or prior to 2012. Alcohol consumption (amount and frequency intake) and alcoholic beverage type were collected in 2006 (baseline) and 2012. Participants were grouped into non-, light- (women: 0-0.4 serving/day; men: 0-0.9 serving/day), moderate- (women: 0.5-1.0 serving/day; men: 1.0-2.0 servings/day), and heavy- (women: >1.0 servings/day; men: >2.0 servings/day) drinker. Overall sleep quality was measured in 2012 and included four sleep parameters (insomnia, daytime sleepiness, sleep duration, snoring/obstructive sleep apnea). Results: We observed a dose-response association between higher alcohol consumption in 2006 and worse sleep quality in 2012 (P-trend <0.001), after adjusting for age, sex, social-economic status, smoking status, physical activity, obesity, plasma lipid profiles, diabetes and hypertension. A similar association was observed when alcohol consumption in 2012 was used as exposure. Alcohol was associated with higher odds of having short sleep duration (adjusted odds ratio for heavy- vs. non-drinkers = 1.32; 95% confidence interval: 1.09-1.57), and snoring (adjusted odds ratio for heavy- vs. non-drinkers: 1.38; 95% confidence interval: 1.22-1.57). Consumption of hard liquor, but not beer or wine, was significantly associated with poor sleep quality. Conclusions: Higher alcohol consumption was associated with poorer sleep quality and higher odds of having snoring and short sleep duration.

show abstract

Section: Participantsmentioning

confidence: 99%

Section: Participantsmentioning

confidence: 99%

Alcohol consumption and sleep quality: a community-based study

Zheng

Yuan

et al. 2020

Public Health Nutr.

Self Cite

View full text Add to dashboard Cite

show abstract

“…Similarly, it was reported in America as Commercial drivers suffer from excessive daytime sleepiness due to age, body mass index and alcohol consumptions (16). Alcohol-impaired driving accidents due to sleepiness also contribute to approximately 31% and 34.1% of all traffic fatalities in the USA and china (17) respectively with common alcohol related crash reports in UK from similar cause (18). A prospective cohort study conducted in Japan showed the other predator for excessive daytime sleepiness to be cigarette smoking (19) (20) (21).…”

Section: Introductionmentioning

confidence: 76%

Prevalence and Association of Daytime Sleepiness among Commercial Vehicle Drivers in Southwestern Ethiopia: A Descriptive Cross-Sectional Study

Berhanu¹,

Abera²,

Demissie³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Sleepiness, the most frequent sub-type of sleep disorders, is an excessive daytime sleepiness which commonly affects commercial drivers than the general population. It contributes to the high prevalence of Road Traffic due to its impact related to psychological stress, decreased productivity and increased risk of accidents both in & out of Ethiopia. Therefore, the current study was designed to elucidate the level of daytime sleepiness and its attributes to contribute to the prevention actions of country’s strategy. Objective: To describe the prevalence and associated factors of daytime sleepiness among commercial vehicle drivers in EthiopiaMethods: Data were collected from 398 randomly selected participants using a validated and pretested questionnaire to assess socio-demographic characteristics and the Epworth Sleepiness Scale (ESS), which assesses daytime sleepiness prevalence. All data were entered into EpiData and analyzed using Statistical Package for Social Science (SPSS) version 22 software whereby measurements of central tendencies and logistic regressions were used to report the results.Results: Overall, 398 public drivers were enrolled into the study making 99% response rate with the mean age of 32.1 years (SD ± 9.1) and 20-29 year modal class. The driving years of the majority (47%) were reported in 0-4 year class. The prevalence of the daytime sleepiness was 21.7% among the study subjects. In final model of logistic regression drivers’ work experience (AOR=13.96, CI=1.18, 11.1, p=0.04), substance users like Tobacco (AOR=2.9, CI=1.1, 7.6, p=0.03) & Alcohol (AOR=6.12, 95% CI=2.32, 6.12, P=0.00), and drivers’ monthly income (AOR=2.49, 95%CI=1.02, 6.06, P=0.04) were demonstrated an association with day time sleepiness.Conclusions: The prevalence of day time sleepiness was relatively high in the studied population group, and factors linked to the problem are driving experiences, substance use and middle level of monthly income. Therefore, we recommend further studies on impacts of day time sleepiness and strategic action on the reduction of the relation.

show abstract

“…Downloaded from inhibitors and tricyclic antidepressants should be discontinued or avoided if possible. 5 Heavy alcohol use may also increase RBD episodes 6 and should be limited in individuals who have exhibited correlations between alcohol use and RBD episodes. Clonazepam and melatonin are most frequently used for symptomatic treatment of RBD, largely based on case series, and a smattering of other medications has also been reported to be effective.…”

Section: Symptomatic Treatments For Rbdmentioning

confidence: 99%

Clinical trials in REM sleep behavioural disorder: challenges and opportunities

Videnović

Arnulf

et al. 2020

J Neurol Neurosurg Psychiatry

View full text Add to dashboard Cite

The rapid eye movement sleep behavioural disorder (RBD) population is an ideal study population for testing disease-modifying treatments for synucleinopathies, since RBD represents an early prodromal stage of synucleinopathy when neuropathology may be more responsive to treatment. While clonazepam and melatonin are most commonly used as symptomatic treatments for RBD, clinical trials of symptomatic treatments are also needed to identify evidence-based treatments. A comprehensive framework for both disease-modifying and symptomatic treatment trials in RBD is described, including potential treatments in the pipeline, cost-effective participant recruitment and selection, study design, outcomes and dissemination of results. For disease-modifying treatment clinical trials, the recommended primary outcome is phenoconversion to an overt synucleinopathy, and stratification features should be used to select a study population at high risk of phenoconversion, to enable more rapid clinical trials. For symptomatic treatment clinical trials, objective polysomnogram-based measurement of RBD-related movements and vocalisations should be the primary outcome measure, rather than subjective scales or diaries. Mobile technology to enable objective measurement of RBD episodes in the ambulatory setting, and advances in imaging, biofluid, tissue, and neurophysiological biomarkers of synucleinopathies, will enable more efficient clinical trials but are still in development. Increasing awareness of RBD among the general public and medical community coupled with timely diagnosis of these diseases will facilitate progress in the development of therapeutics for RBD and associated neurodegenerative disorders.

show abstract

Alcohol consumption and probable rapid eye movement sleep behavior disorder

Cited by 13 publications

References 37 publications

Alcohol consumption and sleep quality: a community-based study

Alcohol consumption and sleep quality: a community-based study

Prevalence and Association of Daytime Sleepiness among Commercial Vehicle Drivers in Southwestern Ethiopia: A Descriptive Cross-Sectional Study

Clinical trials in REM sleep behavioural disorder: challenges and opportunities

Contact Info

Product

Resources

About